Ostarine
|
|
Ostarine Eigenschaften
- Siedepunkt:
- 632.3±55.0 °C(Predicted)
- Dichte
- 1.41±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- L?slichkeit
- DMSO:70.0(Max Conc. mg/mL);179.8(Max Conc. mM)
- Aggregatzustand
- Solid
- pka
- 12.13±0.29(Predicted)
- Farbe
- White to off-white
- InChI
- InChI=1S/C19H14F3N3O3/c1-18(27,11-28-15-6-2-12(9-23)3-7-15)17(26)25-14-5-4-13(10-24)16(8-14)19(20,21)22/h2-8,27H,11H2,1H3,(H,25,26)/t18-/m0/s1
- InChIKey
- JNGVJMBLXIUVRD-SFHVURJKSA-N
- SMILES
- C(NC1=CC=C(C#N)C(C(F)(F)F)=C1)(=O)[C@](O)(C)COC1=CC=C(C#N)C=C1
Sicherheit
Ostarine Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Ostarine is nonsteroidal selective androgen receptor modulator (SARM) used in the treatment of osteoporosis and muscle wasting in animal models. A potential compound for the treatment of hypoactive sexual desire disorder.Origin
Ostarine is an orally bioavailable, nonsteroidal SARM that was developed by Gtx, Inc. in the late 1990s primarily for the treatment of muscle wasting and osteoporosis.Einzelnachweise
[1] NATALIA LECIEJEWSKA . Sex-specific cytotoxicity of ostarine in cardiomyocytes[J]. Molecular and Cellular Endocrinology, 2023, 577: Article 112037. DOI:10.1016/j.mce.2023.112037.[2] HARJOT BEDI. Drug-Induced Liver Injury From Enobosarm (Ostarine), a Selective Androgen Receptor Modulator.[J]. ACG Case Reports Journal, 2021: e00518. DOI:10.14309/crj.0000000000000518.
[3] PJ R, D H, JC C, et al. Ostarine and Ligandrol Improve Muscle Tissue in an Ovariectomized Rat Model.[J]. Front Endocrinol (Lausanne), 2020, 11: 556581.
[4] JAMES T. DALTON. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial[J]. Journal of Cachexia, Sarcopenia and Muscle, 2011, 2 3: 153-161. DOI:10.1007/s13539-011-0034-6.
[5] ADRIAN S DOBS. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.[J]. Lancet Oncology, 2013, 14 4: 335-345. DOI:10.1016/S1470-2045(13)70055-X.
[6] JEFFREY CRAWFORD. Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).[J]. Current Oncology Reports, 2016, 18 6: 37. DOI:10.1007/s11912-016-0522-0.
[7] ALVARO MORALES. Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline.[J]. Canadian Medical Association journal, 2015, 187 18: 1369-1377. DOI:10.1503/cmaj.150033.
[8] Watts D. Ostarine Reviews: shocking results & information about MK2866. SECEC. https://secec.org/ostarine-mk2866/. Accessed May 18, 2020.
Ostarine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Ostarine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 201)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
American HealthyMorph LLC | +8613363867578 |
nancyyuan133@163.com | China | 169 | 58 |
Shanghai Longyu Biotechnology Co., Ltd. | +8619521488211 |
info@longyupharma.com | China | 2556 | 58 |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 |
sales@sarms4muscle.com | China | 10473 | 58 |
Shandong Zhishang New Material Co., Ltd. | +8617653113209 |
sales002@sdzschem.com | China | 3049 | 58 |
hebei hongtan Biotechnology Co., Ltd | +852-6619 3215 +86-17731935328 |
sales03@chemcn.cn | China | 970 | 58 |
Shanghai Likang New Materials Co., Limited | +86-16631818819 +86-17736933208 |
3684455296@qq.com | China | 9300 | 58 |
Shenzhen Wolid Technology Co., Ltd. | +86-18973692398 +86-18973692398 |
david@biopeplab.com | China | 48 | 58 |
Hebei Dangtong Import and export Co LTD | +86-86-4001020630 +8619831957301 |
admin@hbdangtong.com | China | 998 | 58 |
Xiamen Wonderful Bio Technology Co., Ltd. | +8613043004613 |
Sara@xmwonderfulbio.com | China | 283 | 58 |
qingdao future trading Co., Ltd | +86-13335044410 +86-13335044410 |
cui56813@163.com | China | 110 | 58 |
841205-47-8()Verwandte Suche:
- GTx-024
- Ostarine NOT FOR SALE-PATENTED
- EnobosarM
- PropanaMide, 3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoroMethyl)phenyl]-2-hydroxy-2-Methyl-, (2S)-
- MK-2866 (GTx-024)
- (S)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide MK-2866, Ostarine
- (S)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropionamide
- OSTARINE 841205-47-8
- Ostarine(MK2286)
- Ostarine, >=99%
- Ostarine,GTx-024
- (S)-3-(4-Cyanophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide
- (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
- Ostarine
- ENOBOSAM(MK2866) (Ostarine)
- Ostarine (GTx-024,MK-2866)
- CAS 841205-47-8/1202044-20-9 Pharmaceutical Raw Materials Ostarine MK-2866 Enobosarm
- MK2866(GTx-024,Ostarine)
- MK-2886
- ENOBOSAM(MK2866)
- Ostarine MK-286
- OSTARINE;MK-2866;GTX-024;MK2866;GTX024;MK 2866;GTX 024
- OSTARINE;MK-2866;GTX-024;MK2866;GTX024;MK 2866;GTX 024;ENOBOSARM
- Mk 2866 Ostarine Sarms Powder Mk2866
- Qstarine/MK-2866
- (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide USP/EP/BP
- 99% Purity OSTARINE(MK-2866)
- OSTARINE(MK-2866) Pharmaceutical Grade
- High Quality OSTARINE(MK-2866)
- OSTARINE(MK-2866) 99% Purity
- OSTARINE(MK-2866) with High quality
- MK677,MK2866,CAS841205-47-8
- Enobosarm MK-2866
- Qstarine,MK-2866,(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
- enobosarm (ostarine )
- MK2866(S-22)
- Ostarine?/?MK-2866 25mg Tablets
- Ostarine, 10 mM in DMSO
- MK 2866 25mg
- 841205-47-8
- Inhibitors
- SARMs(Selective androgen receptor modulator)
- Hormone Drugs
- Aromatics
- Intermediates & Fine Chemicals
- Pharmaceuticals
- 841205-47-8
- SARMS